We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$254B
AUM Growth
+$235B
Cap. Flow
+$230B
Cap. Flow %
90.52%
Top 10 Hldgs %
17.14%
Holding
3,268
New
2,228
Increased
916
Reduced
59
Closed
11

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$8.24B
2
AAPL icon
Apple
AAPL
+$6.76B
3
AMZN icon
Amazon
AMZN
+$6.52B
4
META icon
Meta Platforms (Facebook)
META
+$4.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.45B

Sector Composition

Rank Sector Weight
1 Technology 18.97%
2 Financials 14.46%
3 Healthcare 12.78%
4 Consumer Discretionary 10.65%
5 Industrials 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FPRX
2226
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$3.13M ﹤0.01%
+518,760
New +$4.96M
STX icon
2227
Seagate
STX
$184B
$3.13M ﹤0.01%
66,364
+57,950
+689% +$2.7M
FWONA icon
2228
Liberty Media Series A
FWONA
$23.6B
$3.12M ﹤0.01%
+90,754
New +$3.17M
RMR icon
2229
The RMR Group
RMR
$332M
$3.12M ﹤0.01%
+66,326
New +$3.57M
AXGN icon
2230
Axogen
AXGN
$2.5B
$3.11M ﹤0.01%
+157,228
New +$3.36M
FOSL icon
2231
Fossil Group
FOSL
$318M
$3.11M ﹤0.01%
+270,511
New +$3.32M
ALLK
2232
DELISTED
Allakos
ALLK
$3.11M ﹤0.01%
+71,791
New +$2.95M
CCF
2233
DELISTED
Chase Corporation
CCF
$3.1M ﹤0.01%
+28,835
New +$2.86M
BCRX icon
2234
BioCryst Pharmaceuticals
BCRX
$2.4B
$3.1M ﹤0.01%
+818,233
New +$4.92M
MIME
2235
DELISTED
Mimecast Limited
MIME
$3.1M ﹤0.01%
66,289
-55,070
-45% -$2.62M
FET icon
2236
Forum Energy Technologies
FET
$835M
$3.1M ﹤0.01%
+45,275
New +$4.31M
OSBC icon
2237
Old Second Bancorp
OSBC
$1.29B
$3.08M ﹤0.01%
+241,548
New +$3.11M
TELL
2238
DELISTED
Tellurian Inc.
TELL
$3.06M ﹤0.01%
+389,303
New +$3.46M
RVI
2239
DELISTED
Retail Value Inc. Common Shares
RVI
$3.05M ﹤0.01%
+954,405
New +$2.93M
WT icon
2240
WisdomTree
WT
$3.22B
$3.05M ﹤0.01%
+493,765
New +$3.35M
CHCT
2241
Community Healthcare Trust
CHCT
$454M
$3.04M ﹤0.01%
+77,033
New +$2.87M
EVH icon
2242
Evolent Health
EVH
$447M
$3.03M ﹤0.01%
+381,649
New +$4.52M
OSG
2243
Octave Specialty Group
OSG
$222M
$3.02M ﹤0.01%
+179,074
New +$3.06M
YETI icon
2244
Yeti Holdings
YETI
$3.95B
$3.02M ﹤0.01%
+104,145
New +$3M
ASTE icon
2245
Astec Industries
ASTE
$1.02B
$3.01M ﹤0.01%
+92,466
New +$3.1M
PVLA
2246
Palvella Therapeutics
PVLA
$2.27B
$3.01M ﹤0.01%
+8,008
New +$2.39M
MTSI icon
2247
MACOM Technology Solutions
MTSI
$23.7B
$3M ﹤0.01%
+198,148
New +$2.99M
DBD
2248
DELISTED
Diebold Nixdorf Incorporated
DBD
$2.97M ﹤0.01%
+324,555
New +$3.39M
STRL icon
2249
Sterling Infrastructure
STRL
$16.7B
$2.96M ﹤0.01%
+220,655
New +$2.84M
RRGB icon
2250
Red Robin
RRGB
$152M
$2.93M ﹤0.01%
+95,875
New +$2.94M

Similar funds

Nuveen's Q2 2019 Portfolio in Review

As of Q2 2019, Nuveen held 3,268 positions worth $254B, up 1,256% from $18.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Nuveen deployed $230B of net new capital in Q2 2019, opening 2,228 new positions and adding to 916 existing holdings. Its largest new stake was Netflix: 33,941,080 shares worth $1.25B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $142M trimmed.

  • Nuveen's largest Q2 2019 buy was Netflix: 33,941,080 shares worth $1.25B.
  • Nuveen added most to Microsoft in Q2 2019, an estimated $8.24B increase.
  • Nuveen's biggest Q2 2019 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $142M.
  • Nuveen fully exited Nuveen ESG Large-Cap Value ETF in Q2 2019, selling an estimated $22M.
  • Nuveen's ten largest holdings make up 17% of its $254B portfolio in Q2 2019.
  • Nuveen opened 2,228 new positions and closed 11 in Q2 2019.
  • Nuveen's portfolio value rose 1,256% quarter-over-quarter to $254B.

Based on Nuveen's 13F filing for Q2 2019, filed 15 Aug 2019.